同种异体富血小板凝胶在难愈性皮肤溃疡中的临床疗效研究

黄红梅; 梁自文; 施宗平; 方勇飞; 喻荷莲; 王泽蓉; 张红; 刁荣华; 蒋天伦

doi:10.16016/j.1000-5404.201703047

您当前的位置：

首页 >

文章列表页 >

同种异体富血小板凝胶在难愈性皮肤溃疡中的临床疗效研究

临床医学 | 更新时间：2026-01-09

- 同种异体富血小板凝胶在难愈性皮肤溃疡中的临床疗效研究
- Clinical efficacy of allogeneic platelet-rich gel in refractory skin ulcer
- 第三军医大学学报 2017年39卷第19期页码：1944-1948
- 作者机构：
  
  1.400038 重庆，第三军医大学西南医院：输血科
  2.400038 重庆，第三军医大学西南医院：内分泌科
  3.400038 重庆，第三军医大学西南医院：皮肤科
  4.400038 重庆，第三军医大学西南医院：中医科
- 作者简介：
  
  [ 蒋天伦，电话：(026)68754166，E-mail：jtianlun@139.com JIANG Tianlun, Tel: 86-26-68754166, E-mail:jtianlun@139.com
- 基金信息：
  
  护理科技创新基金(SWHLKJ-A07)
- DOI：10.16016/j.1000-5404.201703047
  中图分类号： R331.143;R632.1;R944.15
- 收稿：2017-03-08，
  
  修回：2017-06-06，
  
  纸质出版：2017-10-15
- 稿件说明：
移动端阅览
黄红梅, 梁自文, 施宗平, 等. 同种异体富血小板凝胶在难愈性皮肤溃疡中的临床疗效研究[J]. 第三军医大学学报, 2017,39(19):1944-1948.

Hongmei HUANG, Ziwen LIANG, Zongping SHI, et al. Clinical efficacy of allogeneic platelet-rich gel in refractory skin ulcer[J]. Journal of Third Military Medical University, 2017, 39(19): 1944-1948.
黄红梅, 梁自文, 施宗平, 等. 同种异体富血小板凝胶在难愈性皮肤溃疡中的临床疗效研究[J]. 第三军医大学学报, 2017,39(19):1944-1948. DOI： 10.16016/j.1000-5404.201703047.

Hongmei HUANG, Ziwen LIANG, Zongping SHI, et al. Clinical efficacy of allogeneic platelet-rich gel in refractory skin ulcer[J]. Journal of Third Military Medical University, 2017, 39(19): 1944-1948. DOI： 10.16016/j.1000-5404.201703047.

摘要

目的

评价同种异体富血小板凝胶(allogeneic rich platelet gel

APG)治疗难愈性皮肤溃疡的有效性和安全性。

方法

2016年5月至2017年3月，按照难愈性皮肤溃疡的诊断标准，根据研究对象的纳入及排除标准，共筛选51例患者入组。实验前通过计算机产生随机数字表，按入组时间先后顺序将患者随机分为试验组(26例)和对照组(25例)。两组患者治疗前均做细菌培养+药敏实验，并根据其结果给予抗感染治疗和局部溃疡面标准处理。试验组将同种异体APG外敷溃疡面或注射入窦道，再用凡士林油纱覆盖并用3M医用透明敷贴封闭创面，外用纱布敷料包扎；对照组患者选用新型敷料(速愈乐)治疗溃疡面，外用纱布敷料包扎。以溃疡愈合率、总有效率、窦道愈合率、愈合时间及安全性作为疗效评价指标。

结果

试验组26例患者溃疡愈合率为77%(20/26)，总有效率为100%(26/26)，窦道愈合率为100%(4/4)，愈合时间为18~42 d，平均30.5 d。对照组25例患者溃疡愈合率为52%(13/25)，总有效率为68%(17/25)，窦道愈合率为20%(1/5)，愈合时间为21~58 d，平均38.5 d。试验组和对照组治疗前后的血常规，输血前ICT(HBV、HCV、HIV、梅毒)，T细胞亚群计数(CD4、CD8、CD4/CD8的比值)及血小板抗体检测结果，治疗前后比较差异均无统计学意义(

0.05)，治疗过程中均无不良反应，治疗后随访患者均无不适。

结论

同种异体APG用于治疗难愈性皮肤溃疡安全有效。

Abstract

Objective

To evaluate the efficacy and safety of allogeneic platelet-rich gel (APG) in the treatment of refractory skin ulcer.

Methods

Based on the diagnostic standards for refractory skin ulcer and our inclusion and exclusion criteria

a total of 51 patients were enrolled in this study from May 2016 to March 2017. They were randomly divided into the experimental group (

=26) and control group (

=25). On the basis of bacterial culture and drug sensitive experiment before treatment

the patients of both groups were given corresponding antibiotic treatment and standard processing on local ulcer surface. In the experimental group

allogeneic APG was used as topical dressing on the ulcer surface or injected into the fistula

then petrolatum gauze was covered on it

and medical-transparent-application (3M) was used to close wound. Finally the wound was tied up with gauze dressings. In control group

the ulcer surface was treated with a new kind of dressing (Su Yule)

and then the wound was tied up with gauze dressings. The ulcer healing rate

total effective rate

rate of fistula healing

healing time and safety were employed as effectiveness evaluation indexes.

Results

After the treatment

the ulcer healing rate was 77% (20/26)

total effective rate 100% (26/26)

fistula healing rate 100% (4/4)

and healing time ranged from 18 to 42 (mean 30.5) d

in the experimental group. While in the control group

the ulcer healing rate was 52% (13/25)

total effective rate 68% (17/25)

fistula healing rate 20% (1/5)

and healing time ranged from 21 to 58 (mean 38.5) d. No statistical differences were found in the results of blood routine test

ICT examination before transfusion (HBV

HCV

HIV and syphilis)

T cell subsets counts (CD4

CD8 and CD4/CD8 ratio) and platelet antibody test before and after the treatment and between the 2 groups (

0.05). There were no adverse reactions during the treatment or discomfort in the follow-up.

Conclusion

Allogeneic APG is safe and effective in the treatment of refractory skin ulcer.

关键词

Keywords

references

袁南兵, 王椿, 王艳, 等.自体富血小板凝胶在糖尿病难治性皮肤溃疡中的初步应用[J].四川大学学报(医学版), 2007, 38(5): 900-903. DOI: 10.3969/j.issn.1672-173X.2007.05. 041.

YUAN N B, WANG C, WANG Y, et al . The preliminary application of autologous platelet-rich gel used to treat refractory diabetic dermal ulcer[J ] . J Sichuan Univ(Med Sci Edi), 2007, 38(5): 900-903. DOI: 10.3969/j.issn.1672-173X.2007. 05.041.

AYUK S M, ABRAHAMSE H, HOURELD N N. The Role of matrix metalloproteinases in diabetic wound healing in relation to photobiomodulation[J]. J Diabetes Res, 2016, 2016: 2897656. DOI: 10.1155/2016/2897656.

LI L, CHEN D, WANG C, et al .Autologous platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers:A prospective, randomized clinical trial[J ] . Wound Repair Regen, 2015, 23(4): 495-505.DOI: 10.1111/wrr.12294.

冉兴无, 赵纪春.加强多学科协作团队建设, 提高糖尿病周围血管病变与足病的诊治水平[J].四川大学学报(医学版), 2012, 43(5): 728-733.

RAN X W, ZHAO J C. The importance of multidisciplinary foot-care services in the management of diabetic patients with peripheral artery disease and diabetic foot ulcers[J]. J Sichuan Univ(Med Sci Edi), 2012, 43(5): 728-733.

贺赛玉, 单桂秋, 范艳飞, 等.同源异体富血小板凝胶治疗糖尿病足溃疡的疗效[J].广东医学, 2013, 34(1): 129-131. DOI: 10.3969/j.issn.1001-9448.2013.01.055.

HE S Y, SHAN G Q, FAN Y F, et al . The treatment of diabetic foot ulcer with allogeneic platelet gel[J ] . Guangdong Med J, 2013, 34(1): 129-131. DOI: 10.3969/j.issn.1001-9448.2013.01.055.

贾伟涛, 张长青, 王坚镪, 等.富血小板血浆预防骨感染的实验研究[J].中国修复重建外科杂志, 2010, 24(7): 864-870.

JIA W T, ZHANG C Q, WANG J Q, et al . An experimental study on antimicrobial efficacy of platelet-rich plasma for bone infection prophylaxis[J ] . Chin J Repar Reconstruc Surg, 2010, 24(7): 864-870.

叶露露, 单桂秋, 马静, 等.富血小板血浆抑菌作用的研究进展[J].中国输血杂志, 2014, 27(2): 216-219. DOI: 10.13303/j.cjbt.issn.1004-549x.2014.02.0042.

YE L L, SHAN G Q, MA J, et al . The investigation of antibacterial properties of platelet-rich plasma[J ] . Chin J Blood Transfusion, 2014, 27(2): 216-219. DOI: 10.13303/j.cjbt.issn.1004-549x.2014.02.0042.

BURUOUF T, CHOU M L, WU Y W, et al . Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria[J ] . Transfusion, 2013, 53(1): 138-146. DOI: 10.1111/j.1537-2995.2012.03668.x.

DRAGO L, BORTOLIN M, VASSENA C, et al .Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity[J ] . BMC Microbiol, 2013, 13: 47. DOI: 10.1186/1471-2180-13-47.

ZHANG Z Y, HUANG A W, FAN J J, et al . The potential use of allogeneic platelet-rich plasma for large bone defect treatment: immunogenicity and defect healing efficacy[J ] . Cell Transplantation, 2013, 22(1): 175-187. DOI: 10.3727/096368912X653183.

CHUNG T H, BAEK D S, KIM N, et al . Topical allogeneic platelet-rich plasma treatment for a massive cutaneous lesion induced by disseminated intravascular coagulation in a toy breed dog[J ] . Ir Vet J, 2015, 68(1): 4. DOI: 10.1186/s13620-015-0032-7.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据